KalVista Pharmaceuticals, Inc.
DE ˙ DB ˙ US4834971032
23,01 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:4XC1 / KalVista Pharmaceuticals, Inc.
InstitutionWalleye Capital LLC
Latest Disclosed Ownership79,666 shares
Latest Disclosed Value $ 1,603,677
Walleye Capital LLC ownership in 4XC1 / KalVista Pharmaceuticals, Inc.

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 79,666 shares of KalVista Pharmaceuticals, Inc. (DE:4XC1) valued at $1,234,823 USD as of March 31, 2026. The entity filed a previous 13F-HR on August 13, 2025 disclosing 0 shares of KalVista Pharmaceuticals, Inc.. The current value of the position is $1,833,115 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (4XC1) in the form of stock options. The firm currently holds call options representing 2,200 of underlying shares valued at $44,286 USD and put options representing 1,400 of underlying shares valued at $28,182 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:4XC1 / KalVista Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 79,666 79,666 1,604 0.0067
2026-05-08 2026-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 79,666 79,666 1,604 0.0067
2025-08-13 2025-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 0 -249,161 -100.00 0 -100.00
2025-05-14 2025-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 249,161 -18,582 -6.94 2,875 26.82 0.0130
2025-02-13 2024-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 267,743 267,743 2,268 0.0055
2024-08-14 2024-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 0 -120,308 -100.00 0 -100.00
2024-05-15 2024-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 120,308 22,478 22.98 1,427 19.03 0.0025
2024-02-14 2023-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 97,830 39,452 67.58 1,198 113.17 0.0025
2023-11-21 2023-09-30 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 58,378 58,378 562 0.0014
2023-11-14 2023-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 58,378 58,378 562 0.0014
2023-05-15 2023-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 0 -32,482 -100.00 0 -100.00
2023-02-14 2022-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 32,482 -116,385 -78.18 220 -89.86 0.0040
2022-11-14 2022-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 148,867 -55,471 -27.15 2,160 7.41 0.0412
2022-08-19 2022-06-30 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 204,338 140,128 218.23 2,011 112.58 0.0554
2022-08-08 2022-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 204,338 140,128 2,011 0.0554
2022-05-27 2022-03-31 13F/A-01 KALVISTA PHARMACEUTICALS COM 483497103 64,210 64,210 946 0.0253
2022-05-16 2022-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 64,210 64,210 946 0.0193
2020-11-16 2020-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 0 -16,676 -100.00 0 -100.00
2020-08-14 2020-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 16,676 -4,124 -19.83 202 27.04 0.0451
2020-05-15 2020-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 20,800 20,800 159 0.0350
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A KALVISTA PHARMACEUTICALS COM Call 2,200 44 n/a n/a n/a
2026-05-08 2026-03-31 13F KALVISTA PHARMACEUTICALS COM Call 2,200 44 n/a n/a n/a
2025-11-14 2025-09-30 13F KALVISTA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-13 2025-06-30 13F KALVISTA PHARMACEUTICALS COM Call 21,400 242 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A KALVISTA PHARMACEUTICALS COM Put 1,400 28 n/a n/a n/a
2026-05-08 2026-03-31 13F KALVISTA PHARMACEUTICALS COM Put 1,400 28 n/a n/a n/a
2025-11-14 2025-09-30 13F KALVISTA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-13 2025-06-30 13F KALVISTA PHARMACEUTICALS COM Put 100 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.